LGALS1 and pancreatic neoplasm: Along the same line, using a KRas-driven pancreatic cancer mouse model that faithfully recapitulates human PDA progression [71], our group has recently demonstrated that pancreatic tumors developed in a Gal1 KO background display longer latency and lower metastatic capacity, with an increase in animal survival of up to 20% [65].